What type of study is this?

This is a Human Clinical Trial study (also classified as: Quantitative Study, Experimental Study).

September 29, 2025Cancer Research

Abstract B128: Spatial proteomics extend tumour subtype and microenvironment classifications across genotype-phenotype axes of pancreatic cancer

View Full Paper

Ask AI

Bookmark

This study reveals extensive heterogeneity in pancreatic tumours, linking specific phenotypes to their microenvironment.
Using imaging mass cytometry, 83 cell types were profiled in 221 pancreatic tumours, highlighting diverse tumour subtypes.
The analysis of whole genome sequencing identified key genomic aberrations associated with distinct tumour phenotypes and microenvironments.
The findings support the need for integrated multi-modal approaches in cancer research to enhance outcome prediction.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

This analysis uses spatial proteomics and imaging mass cytometry to reveal tumour and microenvironment interactions in pancreatic cancer, suggesting new classification methods.

Cite This Study

Shakfa et al. (2025) studied this question.

synapsesocial.com/papers/68da58dcc1728099cfd113de https://doi.org/10.1158/1538-7445.pancreatic25-b128

View Full Paper

Ask AI

Bookmark

Implication

This analysis uses spatial proteomics and imaging mass cytometry to reveal tumour and microenvironment interactions in pancreatic cancer, suggesting new classification methods.

Abstract B128: Spatial proteomics extend tumour subtype and microenvironment classifications across genotype-phenotype axes of pancreatic cancer

Key Points

Discussion

Implication

Cite This Study

Abstract B128: Spatial proteomics extend tumour subtype and microenvironment classifications across genotype-phenotype axes of pancreatic cancer

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider